IDEAS home Printed from https://ideas.repec.org/h/spr/mgmchp/978-3-031-50032-9_7.html
   My bibliography  Save this book chapter

Case 7 Quidel Corporation

In: Rising Stars

Author

Listed:
  • B. Rajesh Kumar

    (Institute of Management Technology)

Abstract

Quidel Corporation was incorporated in the year 1979 as monoclonal antibodies. The company is a California-based leading diagnostic healthcare manufacturer which has expanded its product base through internal development and acquisition with a focus on developing and manufacturing innovative technologies to enhance the performance of diagnostic testing. QuidelOrtho was created in business combination of Quidel and Ortho Clinical Diagnostics in 2022. QuidelOrtho is ranked among the world’s largest in vitro (IVD) providers in the world. In 1987 the company was reincorporated as Quidel Corporation. Quidel Corporation is involved in the mission to advance diagnostics to improve human health. Quidel holds leadership position in the development, manufacturing, and marketing of rapid diagnostic testing solutions. The company sells its products directly to end users and distributors. In 1983, the company introduced its first products, dipstick-based pregnancy tests. The products are targeted towards professional end users in physician offices, hospitals, clinical and reference laboratories, urgent care clinics, leading universities, retail clinics, pharmacies, and wellness screening centers. The diagnostic solutions offered by the company are utilized for the detection and diagnosis of critical diseases which include infectious diseases, cardiovascular diseases, gastrointestinal diseases, and autoimmune and thyroid diseases. Quidel’s portfolio of products are categorized into four product categories: rapid immunoassay, cardiometabolic immunoassay, molecular diagnostic solutions, and specialized diagnostic solutions. The products are directly sold by the company to end users and distributors for professional use in physician offices, hospitals, clinical laboratories, urgent care clinics, retail clinics, pharmacies, and wellness screening centers. In 2021, the company had an income of $1.69 billion. Quidel focuses on the delivery of a chain of diagnostic solutions from advanced lateral flow and direct fluorescent antibody to molecular diagnostic tests to improve the quality of healthcare. The 5-year holding period return for Quidel stock was 530%.The total revenues grew by 72% on an average basis during the 3-year period 2019–2021.

Suggested Citation

  • B. Rajesh Kumar, 2024. "Case 7 Quidel Corporation," Management for Professionals, in: Rising Stars, pages 51-57, Springer.
    • Handle: RePEc:spr:mgmchp:978-3-031-50032-9_7
    DOI: 10.1007/978-3-031-50032-9_7
    as

    Download full text from publisher

    To our knowledge, this item is not available for download. To find whether it is available, there are three options:
    1. Check below whether another version of this item is available online.
    2. Check on the provider's web page whether it is in fact available.
    3. Perform a search for a similarly titled item that would be available.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:spr:mgmchp:978-3-031-50032-9_7. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.springer.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.